GLGengyu Lu

Gengyu Lu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gengyu Lu has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • Gang Wu

    The Teaching Experiments Center of Traditional Chinese Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China

    2 shared publications
  • Guoyong Xie

    Department of Resources Science of Traditional Chinese Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, China

    2 shared publications
  • Hui Liu

    Yangzhou Center for Food and Drug Control, Yangzhou, China

    2 shared publications
  • Juanjuan Qiao

    Department of Resources Science of Traditional Chinese Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China

    2 shared publications
  • Minjian Qin

    Department of Resources Science of Traditional Chinese Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University

    2 shared publications
  • Chong Wai Liew

    Experimental Drug Development Center, A-Star, Singapore, Singapore

    1 shared publication

Latest Publications

  • Open Access

    Mining of natural diversity enables efficient and expressible peptide asparaginyl ligases

    by Wenyu Du, Shi Qi, Mingming Zhen, Miao Liao, Yang Zhao, Jiahui Ma, Yining Hao, Hui Jiang, Gengyu Lu, Chong Wai Liew, et al.

    Peptide asparaginyl ligases (PALs) are powerful tools for protein engineering but are limited by natural rarity and poor expression. We mine 23 cyclotide-rich Viola species, uncovering 29 PALs that expand the known repertoire to 47. A dual-objective screen identifies VdiPAL1 as the best-performed natural PAL, with twice efficiency of wt-VyPAL2 and 12 mg L-1 soluble expression in E. coli. A broad P2" specificity including Trp/Ile/Leu/Phe/Tyr/Met is discovered across diverse PALs, which enables sequential click-compatible liposome dual-functionalization. 1.8 Å crystal structure of VdiPAL1 reveals a pre-organized near-attack conformation (NAC), supported by constant-pH MD simulations linking pH-dependent reactivity to NAC geometry. Our homology- and structure-based design yields VyOpt1, a quintuple mutant of VyPAL2 with over 24-fold improved expression via enhanced cap-domain foldability in a single design-test cycle. This work expands the PAL family and demonstrates a transferable cap-domain-based engineering strategy, highlighting natural diversity as a powerful driver of enzyme discovery and optimization.


  • Open Access

    Amana hejiaqingii (Liliaceae), a New Species from the Dabie Mountains, China

    by Meizhen Wang, Shenglu Zhang, Jing Wu, Xinxin Zhu, Zongcai Liu, Gengyu Lu, Pan Li

    In this paper, a new species from Central China, Amana hejiaqingii (Liliaceae), is described and illustrated. It resembles A. anhuiensis and A. tianmuensis but differs from A. anhuiensis as it has one white vein on its lower leaf and yellow anthers. It also differs from A. tianmuensis by possessing solitary pink flowers with longer and wider tepals. The principal coordinates analysis separated the three species based on morphological data. Cytological observation showed that A. hejiaqingii is diploid (2n = 2x = 24). Molecular phylogenetic analyses further supported its species delimitation.


  • Open Access

    Influence of different pretreatments and drying methods on the chemical compositions and bioactivities of Smilacis Glabrae Rhizoma

    by Juanjuan Qiao, Gengyu Lu, Gang Wu, Hui Liu, Wanli Wang, Tianmao Zhang, Guoyong Xie, Minjian Qin

    Background: The processing of medicinal plant materials is one of the important factors influencing the components and biological activities of TCMs. Smilax glabra Roxb. is an herbal vine widely distributed in China, and its dried rhizome (Smilacis Glabrae Rhizoma, SGR) is often used in traditional medicines and functional foods. The processing methods of fresh cutting for SGR slices have been included in ancient Chinese herbal works, some local standards of TCMs, and the current Chinese Pharmacopoeia. Nevertheless, to date, the scientific basis for the processing of fresh medicinal materials for SGR slices has not been revealed. Methods: To optimize the processing method for preparing SGR slices from the fresh rhizomes, the chemical compositions of the un-pretreated and pretreated (boiling, steaming) samples before and after drying (sun-drying, shade-drying, oven-drying), and the contents of astilbin isomers in dried SGR were analyzed by UHPLC-Q-TOF-MS/MS and UHPLC-DAD methods, respectively. Then, the antioxidant, anti-inflammatory, xanthine oxidase and α-glucosidase inhibitory activities of the prepared SGR slices were investigated by biological assays. Results: A total of fifty-two compounds were identified from the un-pretreated and pretreated samples and a total of forty-nine compounds were identified from the subsequently dried samples. After pretreated by boiling and steaming, the contents of neoastilbin, neoisoastilbin, and isoastilbin in the prepared samples all increased. As a quality marker of SGR, the content of astilbin was unchanged or decreased slightly compared with that in the un-pretreated samples. During the drying process, the contents of the four astilbin stereoisomers in the un-pretreated samples increased significantly, while those in the pretreated samples had a slight increase or decrease. The effects of different processing methods were sorted according to the bioactivities of the prepared SGR. As a result, SGR slices prepared with no pretreatment followed by a sun-drying process have a higher astilbin content, better bioactivities and more energy savings, representing the optimum processing method for SGR slices. Conclusions: This study reveals the scientific basis for the processing of fresh medicinal materials for SGR slices. The results provide scientific information for the quality control of SGR and its rational applications in herbal medicines and functional foods. Graphical


  • Open Access

    An integrated study of Violae Herba (Viola philippica) and five adulterants by morphology, chemical compositions and chloroplast genomes: insights into its certified plant origin

    by Gengyu Lu, Juanjuan Qiao, Long Wang, Hui Liu, Gang Wu, Yan Zhu, Yucheng Zhao, Guoyong Xie, Minjian Qin

    Background: Viola philippica Cav. is the only original plant for Violae Herba, as described in the Chinese Pharmacopoeia. The quality of this crude drug is affected by several adulterants from congeneric Viola species, and the authentic plant origin of Violae Herba is still controversial. Genome-based identification offers abundant genetic information and potential molecular markers that can be used for the authentication of closely related species. This study aims to investigate the certified origin of Violae Herba and to develop more effective markers for these easily confused species at the genetic level. Methods: We compared the morphology and chemical composition of 18 batches of commercial samples and six widespread medicinal Viola plants used as Violae Herba or its substitutes by TLC and HPLC-Triple-TOF–MS/MS analyses. The complete chloroplast genomes of these species were sequenced and analyzed, including the general features, repeat sequences, mutational hotspots and phylogeny. The complete chloroplast genomes used as superbarcodes and some specific barcodes screened from mutational hotspots were tested for their ability to distinguish Viola species. Results: A comparative study showed that Violae Herba is a multi-origin traditional Chinese medicine. Commercial decoction pieces and the standard reference drug were mainly derived from V. prionantha, clashing with the record in the Chinese Pharmacopoeia. Chloroplast genome analyses of V. philippica and five adulterants indicated that sequence divergence was relatively low within Viola species. By tree-based approaches, the complete chloroplast genomes showed a better discrimination ability and phylogenetic resolution for each Viola species. These results indicate that the whole chloroplast genomes can be used as superbarcodes to differentiate Viola medicinal plants. More specific DNA barcodes could be further developed from the Viola chloroplast genomes for more efficient and rapid identification of commercial Violae Herba and its adulterants. Conclusions: This study has implications for chloroplast genome-based phylogenetic analysis and the authentication of multiple Viola species used as Violae Herba. The legal origin recorded in the Chinese Pharmacopoeia should be further revised to V. prionantha, in line with the commercial Violae Herba in the TCM markets.


  • Open Access

    The complete chloroplast genome sequence of Gynostemma yixingense and comparative analysis with congeneric species

    by Long Wang, Gengyu Lu, Hao Liu, Lijin Huang, Weimin Jiang, Ping Li, Xu Lu

    For the existence of ginsenosides, G. pentaphyllum, the same genus of G. yixingense is known as 'Panax ginseng of Southern China' (Qin et al., 2015). It is an important medicinal plant with a variety of therapeutic effects that include enhancing immunity, lowering cholesterol, regulating blood pressure, anti-inflammatory and anticancer (Wang et al., 2017). G. yixingense contains similar chemical components to G. pentaphyllum, even containing higher ginsenosides (Zhang et al., 2015). In addition, G. yixingense has a sweeter taste that makes it appreciated by consumers (Xiang et al., 2010). G. yixingense is morphologically similar to G. pentaphyllum, which are often confused in identification and application.